Literature DB >> 9373130

Hyperopia correction by noncontact holmium:YAG laser thermal keratoplasty: U.S. phase IIA clinical study with 2-year follow-up.

D D Koch1, T Kohnen, P J McDonnell, R Menefee, M Berry.   

Abstract

PURPOSE: This study was performed to determine the long-term efficacy, safety, and stability of noncontact holmium:yttrium aluminum garnet (Ho:YAG) laser thermal keratoplasty (LTK) for correction of low-to-moderate hyperopia.
METHODS: The authors treated 1 eye each of 28 patients for correction of low-to-moderate hyperopia (up to +3.88 diopters [D] refractive error) using the Sun 1000 Corneal Shaping System (Sunrise Technologies, Inc., Fremont, CA). Treatments were performed with one or two rings of eight spots per ring with centerline diameters of 6 mm (one ring) or 6 and 7 mm (two rings), ten pulses of laser light at 5-Hz pulse repetition frequency, and pulse energies ranging from 208 to 242 mJ. Follow-up was 2 years.
RESULTS: At 2 years after surgery, uncorrected distance visual acuity was improved by 1 or more lines of Snellen visual acuity in 19 (73%) of 26 of the treated eyes. The mean lines gained was 2.5 +/- 2.2/3.3 +/- 2.7 for one- and two-ring treatment groups, respectively. The mean change in spherical equivalent of the subjective manifest refraction was -0.53 +/- 0.33 D/-1.48 +/- 0.58 D for one- and two-ring treatment groups. Regression between 1 and 2 years was 0.01 D and 0.16 D, respectively. In the one-ring treatment group (18 eyes), 13 eyes (72%) had refractive corrections (range, -0.38 to -1.13 D), and 5 eyes (29%) were unchanged (within +0.25 D) relative to their preoperative measurements. In the two-ring treatment group, all eight eyes (100%) had reductions in their hyperopia (range of corrections, -0.38 to -2.25 D). None of the eyes lost two or more lines of spectacle-corrected distance visual acuity. There were no sight-threatening complications.
CONCLUSIONS: This initial U.S. clinical study indicates that noncontact laser thermal keratoplasty treatment of low hyperopia is safe and produces modest but persistent corrections with 2-year follow-up. Expanded studies of this treatment method are warranted.

Entities:  

Mesh:

Year:  1997        PMID: 9373130     DOI: 10.1016/s0161-6420(97)30003-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Conductive keratoplasty for the correction of hyperopia.

Authors:  P A Asbell; R K Maloney; J Davidorf; P Hersh; M McDonald; E Manche
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  Recent advances in refractive surgery.

Authors:  E Y Yu; W B Jackson
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

3.  The surgical correction of moderate hypermetropia: the management controversy.

Authors:  C N McGhee; S Ormonde; T Kohnen; M Lawless; A Brahma; I Comaish
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

4.  Conductive keratoplasty: a radiofrequency-based technique for the correction of hyperopia.

Authors:  Marguerite B McDonald
Journal:  Trans Am Ophthalmol Soc       Date:  2005

5.  Optics of conductive keratoplasty: implications for presbyopia management.

Authors:  Peter S Hersh
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 6.  Corneal Refractive Procedures for the Treatment of Presbyopia.

Authors:  Kareem Moussa; Naz Jehangir; Tova Mannis; Wai L Wong; Majid Moshirfar
Journal:  Open Ophthalmol J       Date:  2017-04-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.